TNF and COVID-19: Body aches was most common SARS-CoV-2 symptom mainly in RD patients    Patients who had infection were older and had other comorbidities   No difference noted in treatment type of RD patients    Prednisone use worsened in COVID and RD if they had prolonged intake of steroids   Anti-TNF-alpha treatment increased SARS-CoV-2  infection risk    No change noted between use of steroids, immunosuppressants, glucocorticoids, and csDMARD